BRPI0917550A2 - derivado de aminopropilideno e composição farmacêutica compreendendo o referido derivado - Google Patents
derivado de aminopropilideno e composição farmacêutica compreendendo o referido derivadoInfo
- Publication number
- BRPI0917550A2 BRPI0917550A2 BRPI0917550A BRPI0917550A BRPI0917550A2 BR PI0917550 A2 BRPI0917550 A2 BR PI0917550A2 BR PI0917550 A BRPI0917550 A BR PI0917550A BR PI0917550 A BRPI0917550 A BR PI0917550A BR PI0917550 A2 BRPI0917550 A2 BR PI0917550A2
- Authority
- BR
- Brazil
- Prior art keywords
- derivative
- pharmaceutical composition
- aminopropylidene
- aminopropylidene derivative
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008199648 | 2008-08-01 | ||
| JP2009127385 | 2009-05-27 | ||
| PCT/JP2009/063645 WO2010013805A1 (ja) | 2008-08-01 | 2009-07-31 | アミノプロピリデン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0917550A2 true BRPI0917550A2 (pt) | 2015-11-17 |
Family
ID=41610499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0917550A BRPI0917550A2 (pt) | 2008-08-01 | 2009-07-31 | derivado de aminopropilideno e composição farmacêutica compreendendo o referido derivado |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8653285B2 (pt) |
| EP (1) | EP2319840B1 (pt) |
| JP (2) | JP5379139B2 (pt) |
| KR (1) | KR101375680B1 (pt) |
| CN (2) | CN104693215B (pt) |
| AU (1) | AU2009277496B2 (pt) |
| BR (1) | BRPI0917550A2 (pt) |
| CA (1) | CA2732282C (pt) |
| DK (1) | DK2319840T3 (pt) |
| ES (1) | ES2561227T3 (pt) |
| HK (2) | HK1159612A1 (pt) |
| PL (1) | PL2319840T3 (pt) |
| PT (1) | PT2319840E (pt) |
| RU (1) | RU2483063C2 (pt) |
| TW (1) | TWI457341B (pt) |
| WO (1) | WO2010013805A1 (pt) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1502857A (fr) * | 1965-10-01 | 1967-11-24 | Sandoz Sa | Nouveaux dérivés du benzo-cyclohepta-thiophène et leur préparation |
| CH531000A (de) * | 1970-03-11 | 1972-11-30 | Sandoz Ag | Verfahren zur Herstellung neuer Benzocycloheptathiophene |
| JPS522393Y2 (pt) * | 1971-02-15 | 1977-01-19 | ||
| CH568312A5 (pt) * | 1972-01-24 | 1975-10-31 | Sandoz Ag | |
| SE388858B (sv) | 1972-09-20 | 1976-10-18 | Sandoz Ag | Analogiforfarande for framstellning av nya 2-alkyl-4(1-alkyl-4-piperidyliden)bensocykloheptatiofenderivat |
| JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| US4882351A (en) * | 1987-10-14 | 1989-11-21 | Roussel Uclaf | Tricyclic compounds |
| JPH06310784A (ja) | 1993-04-22 | 1994-11-04 | Olympus Optical Co Ltd | 半導体レーザの駆動装置 |
| JP3338913B2 (ja) * | 1993-06-29 | 2002-10-28 | 大鵬薬品工業株式会社 | テトラゾール誘導体 |
| US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| EA015491B1 (ru) * | 2003-06-27 | 2011-08-30 | Янссен Фармацевтика Н.В. | ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ |
| CN101228154B (zh) * | 2005-06-17 | 2014-01-29 | 詹森药业有限公司 | 包含环状胺侧链的四环四氢呋喃衍生物 |
| JP2008019121A (ja) | 2006-07-12 | 2008-01-31 | Babcock Hitachi Kk | 水素製造装置 |
| CN101522665B (zh) * | 2006-09-29 | 2012-02-08 | 日本脏器制药株式会社 | *庚英衍生物 |
| EP2243778B1 (en) * | 2008-01-30 | 2014-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Piperidine derivative |
-
2009
- 2009-07-31 PT PT98030430T patent/PT2319840E/pt unknown
- 2009-07-31 WO PCT/JP2009/063645 patent/WO2010013805A1/ja active Application Filing
- 2009-07-31 PL PL09803043T patent/PL2319840T3/pl unknown
- 2009-07-31 JP JP2010522760A patent/JP5379139B2/ja active Active
- 2009-07-31 KR KR1020117000685A patent/KR101375680B1/ko active IP Right Grant
- 2009-07-31 RU RU2011107744/04A patent/RU2483063C2/ru not_active IP Right Cessation
- 2009-07-31 TW TW098125787A patent/TWI457341B/zh not_active IP Right Cessation
- 2009-07-31 US US13/055,780 patent/US8653285B2/en active Active
- 2009-07-31 CN CN201510017600.3A patent/CN104693215B/zh not_active Expired - Fee Related
- 2009-07-31 BR BRPI0917550A patent/BRPI0917550A2/pt not_active IP Right Cessation
- 2009-07-31 AU AU2009277496A patent/AU2009277496B2/en not_active Ceased
- 2009-07-31 DK DK09803043.0T patent/DK2319840T3/en active
- 2009-07-31 CN CN200980130369.1A patent/CN102112462B/zh not_active Expired - Fee Related
- 2009-07-31 EP EP09803043.0A patent/EP2319840B1/en active Active
- 2009-07-31 ES ES09803043.0T patent/ES2561227T3/es active Active
- 2009-07-31 CA CA2732282A patent/CA2732282C/en not_active Expired - Fee Related
-
2011
- 2011-12-28 HK HK11113986.6A patent/HK1159612A1/xx not_active IP Right Cessation
-
2013
- 2013-09-25 JP JP2013198040A patent/JP5503793B2/ja active Active
-
2015
- 2015-08-03 HK HK15107411.9A patent/HK1206742A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102112462B (zh) | 2015-02-18 |
| DK2319840T3 (en) | 2016-01-25 |
| CA2732282A1 (en) | 2010-02-04 |
| RU2011107744A (ru) | 2012-09-10 |
| JP5503793B2 (ja) | 2014-05-28 |
| ES2561227T3 (es) | 2016-02-25 |
| JP5379139B2 (ja) | 2013-12-25 |
| AU2009277496B2 (en) | 2013-09-26 |
| KR101375680B1 (ko) | 2014-03-19 |
| PL2319840T3 (pl) | 2016-03-31 |
| PT2319840E (pt) | 2016-02-10 |
| HK1159612A1 (en) | 2012-09-21 |
| JPWO2010013805A1 (ja) | 2012-01-12 |
| EP2319840A4 (en) | 2012-05-16 |
| AU2009277496A1 (en) | 2010-02-04 |
| CN104693215A (zh) | 2015-06-10 |
| CA2732282C (en) | 2016-03-29 |
| CN104693215B (zh) | 2017-09-01 |
| WO2010013805A1 (ja) | 2010-02-04 |
| RU2483063C2 (ru) | 2013-05-27 |
| TWI457341B (zh) | 2014-10-21 |
| HK1206742A1 (en) | 2016-01-15 |
| TW201011038A (en) | 2010-03-16 |
| EP2319840B1 (en) | 2015-12-16 |
| US20110124856A1 (en) | 2011-05-26 |
| JP2013253115A (ja) | 2013-12-19 |
| EP2319840A1 (en) | 2011-05-11 |
| KR20110049773A (ko) | 2011-05-12 |
| US8653285B2 (en) | 2014-02-18 |
| CN102112462A (zh) | 2011-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI1013642A2 (pt) | derivado de triazina e composição farmacêutica compreendendo o mesmo | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK3345625T3 (da) | Farmaceutisk sammensætning og indgivelser deraf | |
| BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes | |
| BRPI0908132A2 (pt) | Composto de benzodiazepina e composição farmacêutica | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| DK2285357T3 (da) | Farmaceutisk sammensætning omfattende brivaracetam | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BRPI0820198A2 (pt) | composições farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2473 DE 29-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |